Concepedia

Feng Shi

FS

Statistics

Publications

7

Citations

217

H-Index

7

Active since

2021

Affiliations

Renmin Hospital of Wuhan University(Current)

Wuhan University

Huazhong University of Science and Technology

Hubei Cancer Hospital

Zhejiang University

Feng Shi is an author at Renmin Hospital of Wuhan University specializing in cancer biomarkers, oncology, and medicine.

ORCID

Publications per year

2021–2023

7

Publications

7

Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway

Qi Tian, Yujia Guo, Feng Shi et al. · Journal of Neuroinflammation · 2022 · 80 citations · Full text

, , +17

The Hypoxia‐Related Gene COL5A1 Is a Prognostic and Immunological Biomarker for Multiple Human Tumors

Hua Zhu, Xinyao Hu, Feng Shi et al. · Oxidative Medicine and Cellular Longevity · 2022 · 36 citations · Full text

, , +17

Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning–based cuproptosis‐related signature is identified for predicting prognosis and immunotherapy response of gliomas

Feng Shi, Yonggang Zhang, Hua Zhu et al. · CNS Neuroscience & Therapeutics · 2023 · 25 citations · Full text

, , +17

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma

Kai Yu, Yulong Ji, Min Liu et al. · Frontiers in Immunology · 2022 · 23 citations · Full text

, , +17

Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome

Dan Li, Tao Yu, Junjie Hu et al. · Oxidative Medicine and Cellular Longevity · 2021 · 19 citations · Full text

, , +17

1–5 of 7